Last updated: 11/03/2018 11:33:57

Study to identify and characterize bacteria causing Acute Otitis Media in young children in Turkey

GSK study ID
111339
Clinicaltrials.gov ID
EudraCT ID
Not applicable
EU CT Number
Not applicable
Trial status
Cancelled
Cancelled
Overview
Eligibility
Locations
Study documents
Results summary
Plain language summaries
Additional information

Trial overview

Official title: Identification and characterization of the bacteria causing Acute Otitis Media (AOM) episodes in young children in Turkey
Trial description: The purpose of this study is to identify and characterize the bacteria causing complicated Acute Otitis Media episode in children >= 3 months to < 5 years in Turkey.
Primary purpose:
Not applicable
Trial design:
Not applicable
Masking:
Not applicable
Allocation:
Not applicable
Primary outcomes:

Occurrence of bacterial pathogens isolated from middle ear fluid samples.

Timeframe: Not Applicable.

Secondary outcomes:

Occurrence of bacterial serotypes.

Timeframe: Not Applicable.

Antimicrobial susceptibility of bacteria isolated from middle ear fluid samples collected from sub-groups of complicated acute otitis media cases.

Timeframe: Not Applicable.

Occurrence of treatment failure of acute otitis media and of recurrent acute otitis media.

Timeframe: Not Applicable.

Occurrence of bacteria in acute otitis media cases vaccinated with a pneumococcal vaccine.

Timeframe: Not Applicable.

Occurrence of spontaneous otorrhoea.

Timeframe: Not Applicable.

Interventions:
Procedure/surgery: Tympanocenthesis and urine collection
Enrollment:
0
Observational study model:
Case-Only
Primary completion date:
Not applicable
Time perspective:
Prospective
Clinical publications:
Not applicable
Medical condition
Infections, Streptococcal
Product
GSK2647154A
Collaborators
Not applicable
Study date(s)
November 2012 to February 2014
Type
Observational
Phase
Not applicable

Participation criteria

Sex
Female & Male
Age
3 months - 5 years
Accepts healthy volunteers
No
  • Age: >= 3 months and < 5 years at the time they are seen by the paediatrician. The subject becomes ineligible on the fifth birthday.
  • Signs, symptoms, and conditions:
  • Hospitalised during the diagnosis of acute otitis media or during treatment.
  • Otitis externa, or otitis media with effusion.

Trial location(s)

Location
Status
Contact us
Contact us
Location
GSK Investigational Site
Istanbul, Turkey
Status
Will Be Recruiting
Location
GSK Investigational Site
Izmir, Turkey
Status
Will Be Recruiting
Location
GSK Investigational Site
Adana, Turkey
Status
Terminated/Withdrawn
Location
GSK Investigational Site
Ankara, Turkey
Status
Will Be Recruiting
Location
GSK Investigational Site
Izmir, Turkey, 35100
Status
Will Be Recruiting

Study documents

No study documents available.

Results overview

No study documents available

Recruitment status
Cancelled
Actual primary completion date
Not applicable
Actual study completion date
Not applicable

Plain language summaries

Not applicable. GSK’s transparency policy provides for Plain Language Summaries for Interventional studies.

Additional information about the trial

Not applicable
Participate in clinical trial
Access to clinical trial data by researchers
Visit website